• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessment of real-world application of advanced prostate cancer management in Japan.

作者信息

Aragon-Ching Jeanny B

机构信息

GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA, USA.

Department of Medicine, University of Virginia, Charlottesville, VA, USA.

出版信息

Transl Androl Urol. 2022 Dec;11(12):1614-1617. doi: 10.21037/tau-22-765.

DOI:10.21037/tau-22-765
PMID:36632149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9827408/
Abstract
摘要

相似文献

1
Assessment of real-world application of advanced prostate cancer management in Japan.日本晚期前列腺癌管理的真实世界应用评估。
Transl Androl Urol. 2022 Dec;11(12):1614-1617. doi: 10.21037/tau-22-765.
2
Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference.日本晚期前列腺癌患者的管理：对晚期前列腺癌共识会议结果的“真实世界”考量
Transl Androl Urol. 2022 Dec;11(12):1771-1785. doi: 10.21037/tau-22-396.
3
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.转移性前列腺癌中，起始雄激素通路阻断后前列腺特异性膜抗原正电子发射断层扫描示踪剂摄取出现异质性 flares。
Eur Urol Oncol. 2018 May;1(1):78-82. doi: 10.1016/j.euo.2018.03.010. Epub 2018 May 15.
4
The effect of androgen deprivation therapy on Ga-PSMA tracer uptake in non-metastatic prostate cancer patients.雄激素剥夺疗法对非转移性前列腺癌患者镓-前列腺特异性膜抗原（Ga-PSMA）示踪剂摄取的影响。
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):632-641. doi: 10.1007/s00259-019-04581-4. Epub 2019 Nov 15.
5
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation.前列腺特异性膜抗原正电子发射断层扫描检测到的寡转移性复发性前列腺癌接受转移灶定向放疗：雄激素剥夺治疗的添加及持续时间的作用
Eur Urol Focus. 2021 Mar;7(2):309-316. doi: 10.1016/j.euf.2019.08.012. Epub 2019 Sep 5.
6
Flare on [F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients.短期雄激素剥夺治疗后 [F]PSMA-1007 PET/CT flares 及其与 FDG 摄取的相关性：初治转移性前列腺癌患者肿瘤侵袭性的可能标志物。
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):613-621. doi: 10.1007/s00259-022-05970-y. Epub 2022 Sep 26.
7
Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer.在未经治疗的前列腺癌男性患者中，关于短期雄激素剥夺疗法对PSMA摄取影响的前瞻性研究，采用Ga-PSMA-11 PET/MRI进行评估。
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):665-673. doi: 10.1007/s00259-019-04635-7. Epub 2019 Dec 26.
8
Impact of Three-Month Androgen Deprivation Therapy on [68Ga]Ga-PSMA-11 PET/CT Indices in Men with Advanced Prostate Cancer-Results from a Pilot Prospective Study.三个月雄激素剥夺疗法对晚期前列腺癌男性患者[68Ga]镓-PSMA-11 PET/CT指标的影响——一项前瞻性初步研究的结果
Cancers (Basel). 2022 Mar 4;14(5):1329. doi: 10.3390/cancers14051329.
9
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer.前列腺特异性膜抗原正电子发射断层扫描作为生物标志物评估晚期前列腺癌患者的治疗反应。
Eur Urol Focus. 2023 Jul;9(4):596-605. doi: 10.1016/j.euf.2023.02.001. Epub 2023 Feb 25.
10
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.前列腺特异性膜抗原正电子发射断层扫描在新发和生化复发前列腺癌中的应用对转移灶位置的影响及对患者管理的影响：一项关键性综述。
Eur Urol Oncol. 2023 Apr;6(2):128-136. doi: 10.1016/j.euo.2023.01.014. Epub 2023 Feb 16.

本文引用的文献

1
Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference.日本晚期前列腺癌患者的管理：对晚期前列腺癌共识会议结果的“真实世界”考量
Transl Androl Urol. 2022 Dec;11(12):1771-1785. doi: 10.21037/tau-22-396.
2
Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now.低风险转移性激素敏感性前列腺癌的治疗强化：时机已至。
Eur Urol Open Sci. 2022 Sep 28;45:41-43. doi: 10.1016/j.euros.2022.09.009. eCollection 2022 Nov.
3
Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer.转移性去势敏感型前列腺癌患者的强化治疗模式和利用情况。
Clin Genitourin Cancer. 2022 Dec;20(6):524-532. doi: 10.1016/j.clgc.2022.06.017. Epub 2022 Jun 28.
4
More Unacceptable Denials: Now It's PSMA-Targeted PET/CT Imaging.更多不可接受的拒绝：现在是靶向PSMA的PET/CT成像。
J Nucl Med. 2022 Jul;63(7):969-970. doi: 10.2967/jnumed.121.264374.
5
With New Technology Comes Great Responsibility: Prostate-Specific Membrane Antigen Imaging in Recurrent Prostate Cancer.新技术带来重大责任：复发性前列腺癌中的前列腺特异性膜抗原成像
J Clin Oncol. 2022 Sep 10;40(26):3015-3019. doi: 10.1200/JCO.22.00493. Epub 2022 Jun 3.
6
Radiotherapy of oligometastatic prostate cancer: a systematic review.寡转移前列腺癌的放射治疗：系统评价。
Radiat Oncol. 2021 Mar 9;16(1):50. doi: 10.1186/s13014-021-01776-8.
7
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.晚期前列腺癌患者的管理：2019年晚期前列腺癌共识会议报告
Eur Urol. 2020 Apr;77(4):508-547. doi: 10.1016/j.eururo.2020.01.012. Epub 2020 Jan 27.
8
A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer.前列腺癌中 DNA 损伤反应基因突变的流行情况系统评价。
Int J Oncol. 2019 Sep;55(3):597-616. doi: 10.3892/ijo.2019.4842. Epub 2019 Jul 16.
9
Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?恩杂鲁胺、阿帕鲁胺或达罗他胺：苹果还是香蕉对患者最有益？
Nat Rev Urol. 2019 Jun;16(6):335-336. doi: 10.1038/s41585-019-0186-2.
10
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.胰腺癌的流行病学：全球趋势、病因及风险因素
World J Oncol. 2019 Feb;10(1):10-27. doi: 10.14740/wjon1166. Epub 2019 Feb 26.